Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02527278 · ClinicalTrials.gov registry record
Retrospective Claims Analysis of Hysterectomy After Sterilization
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 19,317
- Enrollment target
NCT02527278: Completed study, sponsored by Bayer.
NCT02527278 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 19,317 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02527278 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 19,317 participants
- Enrollment target
Study Summary
The research questions are: 1. What is the proportion of women undergoing hysterectomy after hysteroscopic sterilization or laparoscopic tubal ligation? 2. What is the proportion of women undergoing salpingectomy, salpingostomy, or hysteroscopy after hysteroscopic sterilization or laparoscopic tubal ligation? 3. What is the proportion of women who have a diagnosis of pelvic pain after hysteroscopic sterilization or laparoscopic tubal ligation?
Interventions
- PROCEDURE Laparoscopic tubal ligation
- PROCEDURE Hysteroscopic sterilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,317 participants |
| Start Date | 2015-07-30 |
| Est. Completion | 2016-02-09 |
What the finished NCT02527278 record still lists
NCT02527278 is an observational study that tracks outcomes without assigning an intervention. Its 19,317 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Laparoscopic tubal ligation is the first listed.
NCT02527278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02527278 about?
NCT02527278 is a clinical study titled "Retrospective Claims Analysis of Hysterectomy After Sterilization". The research questions are: 1. What is the proportion of women undergoing hysterectomy after hysteroscopic sterilization or laparoscopic tubal ligation? 2. What is the proportion of women undergoing salpingectomy, salpingostomy, or hysteroscopy after hysteroscopic sterilization or laparoscopic tuba...
What is the current status of trial NCT02527278?
This trial is currently completed. The enrollment target is 19,317 participants. The study started on 2015-07-30. Estimated completion is 2016-02-09.
What interventions are being tested in trial NCT02527278?
The interventions under investigation include: Laparoscopic tubal ligation (PROCEDURE), Hysteroscopic sterilization (PROCEDURE).
Who is sponsoring clinical trial NCT02527278?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05555095 · 19,331 participants
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- NCT07152249 · 19,480 participants · NA
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI